Generic Desloratadine ( Desloratadine )

Order cheap Generic Desloratadine (Desloratadine) without dr prescription in the United States

In our USA pharmacy, you can buy Desloratadine without a prescription, with delivery across the USA within 2‑5 days. Discreet and anonymous packaging.
Desloratadine is a long‑acting, non‑sedating second‑generation antihistamine that provides effective relief from allergy symptoms, including sneezing, runny nose, itchy or watery eyes, and itching of the nose or throat. It is the active metabolite of loratadine and works by selectively blocking peripheral histamine H1 receptors, inhibiting the release of inflammatory mediators from mast cells without significant entry into the brain.
Usual adult dose: 5 mg once daily, with or without food. The tablet can be swallowed whole with water.
Dosage form: Film‑coated oral tablet (5 mg).
Onset of action: Symptom relief typically begins within 1 hour; peak antihistaminic effect occurs at 3‑4 hours after dosing.
Duration of action: A single 5 mg dose provides 24‑hour symptom control.
Alcohol consumption does not appear to enhance the sedative effects of desloratadine; moderate alcohol intake is generally acceptable, but heavy drinking should be avoided as it may worsen allergy symptoms or cause drowsiness.
Most common side effects: dry mouth, fatigue, pharyngitis, and myalgia (muscle pain); these are usually mild and occur infrequently.
Would you like to try Desloratadine without a prescription?

General Information about Desloratadine

• INN (International Nonproprietary Name): Desloratadine
• Brand names available in the USA: Clarinex® (Organon LLC, a subsidiary of Organon & Co.). Generic desloratadine tablets are available from multiple manufacturers, including Teva Pharmaceuticals USA, Inc., Mylan Pharmaceuticals Inc., and others.
• ATC code: R06AX27
• Dosage forms and strengths: Film‑coated tablets containing 5 mg of desloratadine. (Also available as orally disintegrating tablets 2.5 mg and 5 mg, and as an oral solution 0.5 mg/mL.)
• Manufacturers in USA: Organon LLC (brand Clarinex®); generic manufacturers include Teva Pharmaceuticals USA, Inc., Mylan Pharmaceuticals Inc., and other FDA‑approved generic drug producers.
• Registration status in USA: Approved by the U.S. Food and Drug Administration (FDA) on December 21, 2001 (NDA 021165).
• OTC / Rx classification: Prescription only (Rx).

Mechanism of Action and Pharmacology

Desloratadine is the primary active metabolite of loratadine, a non‑sedating, long‑acting tricyclic antihistamine. It binds selectively and with high affinity to peripheral histamine H1 receptors, thereby inhibiting the action of histamine on capillary permeability, vasodilation, and sensory nerve endings. Unlike first‑generation antihistamines, desloratadine is a substrate for the P‑glycoprotein efflux transporter, which limits its penetration across the blood‑brain barrier, resulting in minimal central nervous system effects. In addition to its antihistaminic activity, desloratadine possesses anti‑inflammatory properties; it inhibits the release of histamine, tryptase, prostaglandin D2, and leukotriene C4 from mast cells and basophils, and down‑regulates the expression of adhesion molecules. Following oral administration, the tablet is well absorbed from the gastrointestinal tract, and food does not significantly affect its bioavailability. Peak plasma concentrations are reached approximately 3 hours after dosing, and the drug is highly protein‑bound (82‑87%). Desloratadine is extensively metabolized by the liver to 3‑hydroxy‑desloratadine, which is subsequently glucuronidated. The elimination half‑life of desloratadine is approximately 27 hours, allowing for once‑daily dosing, and steady‑state is achieved after about 7 days. Elimination occurs primarily via the urine and feces as metabolites.

Indications

• Relief of nasal and non‑nasal symptoms of seasonal allergic rhinitis (hay fever) in adults and children 2 years of age and older.
• Relief of symptoms of perennial allergic rhinitis in adults and children 6 months of age and older.
• Symptomatic treatment of chronic idiopathic urticaria (hives) in adults and children 6 months of age and older to reduce pruritus and the number of wheals.

Important Warnings and Precautions

Desloratadine is generally well‑tolerated, but caution is advised in patients with renal or hepatic impairment due to altered pharmacokinetics; dose adjustment is recommended in patients with severe renal insufficiency. Although it has very low sedative potential, some individuals may experience somnolence; patients should avoid driving or operating hazardous machinery until they know how the medication affects them. Use with caution in patients with a history of seizure disorders, as antihistamines may rarely lower the seizure threshold. Hypersensitivity reactions, including rash, pruritus, and angioedema, have been reported; discontinue immediately if they occur. The safety and efficacy of desloratadine in children under 6 months of age have not been established, and the orally disintegrating tablets are not recommended for children under 6 years. Do not exceed the recommended dose.

At‑risk groups

• Elderly: No dose adjustment is required based solely on age. However, elderly patients are more likely to have decreased renal or hepatic function, so monitoring is appropriate.
• Pregnancy: There are no adequate and well‑controlled studies in pregnant women. Desloratadine should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. The drug did not show teratogenic effects in animal studies, but high doses were associated with decreased pup survival.
• Breastfeeding: Desloratadine passes into breast milk. Because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the medication to the mother. Caution is advised.
• Renal impairment: In patients with severe renal insufficiency (creatinine clearance
• Hepatic impairment: No dose adjustment is required for mild to moderate hepatic impairment. For severe hepatic impairment, a dose of 5 mg every other day is recommended.
• Pediatric: For children 6‑11 months: 2 mL of oral solution (1 mg) once daily. For children 1‑5 years: 2.5 mL (1.25 mg) once daily. For children 6‑11 years: 2.5 mg once daily. For adolescents 12 years and older: adult dosing (5 mg once daily). The 5 mg tablet is appropriate for patients 12 years and older. Not recommended for children under 6 months.

Driving and alcohol

Desloratadine is a non‑sedating antihistamine; however, rare cases of somnolence have been reported. Patients should exercise caution when driving or operating machinery until they know how the drug affects them. Alcohol does not appear to potentiate the central nervous system effects of desloratadine to a clinically significant degree. Moderate alcohol consumption is acceptable, but heavy drinking may worsen allergic symptoms and increase the risk of drowsiness.

Dosage Instructions

• Adults and adolescents 12 years of age and older: 5 mg once daily.
• Children 6‑11 years: 2.5 mg once daily. The 5 mg tablet is not suitable for this age group; use the orally disintegrating tablet or oral solution.
• Children 1‑5 years: 1.25 mg once daily (oral solution).
• Children 6‑11 months: 1 mg once daily (oral solution).
• Renal or severe hepatic impairment: For adults and children 12 years and older, the recommended dose is 5 mg every other day. For younger children with renal impairment, consult a specialist.
• Administration: Swallow the tablet whole with water. May be taken with or without food. Do not crush or chew. If using the orally disintegrating tablet, place on the tongue and allow to dissolve before swallowing; no liquid is needed.
• Missed dose: If a dose is missed, take it as soon as remembered. If it is nearly time for the next dose, skip the missed dose and resume the regular schedule. Do not double the dose.

Side Effects and Contraindications

Most common side effects (incidence ≥2% and greater than placebo): Dry mouth (5%), fatigue (2‑4%), pharyngitis (3%), myalgia (2%), somnolence (2%), and dysmenorrhea (2%). These are generally mild and transient.
Other adverse reactions: Nausea, diarrhea, dizziness, headache, and dyspepsia have been reported. In children, fever, cough, and upper respiratory tract infection occurred more frequently.
Serious adverse reactions: Hypersensitivity reactions including anaphylaxis, angioedema, rash, and pruritus (rare). No clinically significant cardiac arrhythmias or QTc prolongation have been observed, even at doses up to 45 mg/day (9 times the recommended dose).
Absolute contraindications: Known hypersensitivity to desloratadine, loratadine, or any excipient in the formulation.

Drug Interactions

• Erythromycin and ketoconazole: Co‑administration increases desloratadine exposure, but the increase is not clinically significant and no dose adjustment is required.
• Cimetidine: Slightly increases desloratadine levels, but this is not clinically meaningful.
• Fluoxetine: Minimal effect on desloratadine pharmacokinetics; no interaction of clinical relevance.
• Alcohol: No clinically significant pharmacodynamic interaction; desloratadine does not enhance alcohol‑induced impairment. Moderation is advised.
• Grapefruit juice: Does not significantly affect desloratadine bioavailability, unlike some other antihistamines.
• Desloratadine does not inhibit or induce cytochrome P450 enzymes, making metabolic drug interactions unlikely.

Practical Advice

• Take desloratadine exactly as prescribed, once daily, with or without food.
• If you miss a dose, take it as soon as you remember. Do not take two doses at the same time.
• This medication is non‑sedating for most people; however, if you feel sleepy, avoid driving or operating heavy machinery until you know how it affects you.
• Limit alcohol intake; heavy drinking may make allergic symptoms worse.
• If you have kidney or liver problems, inform your healthcare provider, as a different dosing schedule may be necessary.
• Store the tablets at room temperature (15‑30°C / 59‑86°F), protected from moisture and light. Keep out of reach of children.
• If symptoms persist or worsen after 7 days, or if you develop a new rash, consult a doctor.
• Do not share your medication with others.

Alternative Medications

• Loratadine (Claritin®): The parent drug; non‑sedating, available OTC. May be slightly less effective at equivalent doses but has a similar safety profile.
• Cetirizine (Zyrtec®): Another second‑generation antihistamine with a higher incidence of sedation but a faster onset. Available OTC.
• Fexofenadine (Allegra®): A non‑sedating antihistamine that requires an empty stomach for optimal absorption. Available OTC.
• Levocetirizine (Xyzal®): The active isomer of cetirizine; effective at a lower dose with similar sedation potential. Available OTC.
• Intranasal corticosteroids (fluticasone Flonase®, triamcinolone Nasacort®): For first‑line long‑term management of allergic rhinitis; can be used alone or with an oral antihistamine.
• Bilastine (Ilaxten®): Not available in the USA, but used in other countries as a non‑sedating option.

Clinical Efficacy

The clinical efficacy of desloratadine has been established in multiple randomized, double‑blind, placebo‑controlled trials for seasonal allergic rhinitis, perennial allergic rhinitis, and chronic idiopathic urticaria. In patients with seasonal rhinitis, a single daily 5 mg dose significantly reduced total nasal and non‑nasal symptom scores compared with placebo, with onset of action within 1 hour and sustained benefit over 24 hours. In perennial rhinitis, long‑term studies demonstrated sustained efficacy with no development of tolerance over up to 6 months. For chronic urticaria, desloratadine significantly decreased pruritus scores and the number of wheals compared with placebo, with a safety profile comparable to other second‑generation antihistamines. Desloratadine was non‑inferior to cetirizine and fexofenadine in head‑to‑head trials, with the advantage of less sedation than cetirizine. It has no known cardiotoxicity and is considered a first‑line option for allergic conditions.

Important:

Desloratadine is a prescription antihistamine available as a 5 mg tablet. It is generally well tolerated, but it may cause mild drowsiness in some individuals. Do not exceed the recommended dose. If you have kidney or liver problems, your dosing schedule may need to be adjusted. Pregnant or breastfeeding women should discuss use with their healthcare provider. Stop taking the medication and seek medical attention if you develop signs of an allergic reaction such as rash, swelling, or difficulty breathing. Keep out of reach of children. Do not use this product to treat anaphylaxis; it is not a substitute for emergency epinephrine. Use exactly as prescribed and never share your medication.

How to buy Generic Desloratadine no prescription U.S. Online Pharmacy